nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute GVHD: do we trust our gut?
|
Chen, Yi-Bin |
|
|
137 |
11 |
p. 1447-1448 |
artikel |
2 |
A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia
|
Tan, Yun |
|
|
137 |
11 |
p. 1503-1516 |
artikel |
3 |
Cabot rings in acute myeloid leukemia
|
Raslan, Omar |
|
|
137 |
11 |
p. 1560 |
artikel |
4 |
Dietary iron restriction improves markers of disease severity in murine sickle cell anemia
|
Parrow, Nermi L. |
|
|
137 |
11 |
p. 1553-1555 |
artikel |
5 |
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
|
Gandhi, M.K. |
|
|
137 |
11 |
p. 1468-1477 |
artikel |
6 |
Editorial Board
|
|
|
|
137 |
11 |
p. i |
artikel |
7 |
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
|
Khan, Niloufer |
|
|
137 |
11 |
p. 1527-1537 |
artikel |
8 |
FGF-23: a novel actor in stem cell mobilization
|
Calvi, Laura M. |
|
|
137 |
11 |
p. 1434-1436 |
artikel |
9 |
FGF-23 from erythroblasts promotes hematopoietic progenitor mobilization
|
Ishii, Shinichi |
|
|
137 |
11 |
p. 1457-1467 |
artikel |
10 |
Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma
|
Shimada, Kazuyuki |
|
|
137 |
11 |
p. 1491-1502 |
artikel |
11 |
Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations
|
Yang, Wenjian |
|
|
137 |
11 |
p. 1550-1552 |
artikel |
12 |
Intravascular lymphoma: from vessels to genes
|
Patriarca, Andrea |
|
|
137 |
11 |
p. 1438-1439 |
artikel |
13 |
Less (Fe) is more (Hb) in SCA
|
Brugnara, Carlo |
|
|
137 |
11 |
p. 1446-1447 |
artikel |
14 |
Let's reconstitute microbiota diversity
|
Malard, Florent |
|
|
137 |
11 |
p. 1442-1444 |
artikel |
15 |
Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients
|
Greco, Raffaella |
|
|
137 |
11 |
p. 1556-1559 |
artikel |
16 |
PML-RARα: changing myeloid networks
|
Kogan, Scott C. |
|
|
137 |
11 |
p. 1439-1440 |
artikel |
17 |
Protect our children: Hodgkin lymphoma survivors
|
Bartlett, Nancy L. |
|
|
137 |
11 |
p. 1433-1434 |
artikel |
18 |
Resolving thromboinflammation
|
McAdoo, Stephen P. |
|
|
137 |
11 |
p. 1444-1446 |
artikel |
19 |
Sorting biologic subtypes of primary CNS lymphoma
|
Roschewski, Mark |
|
|
137 |
11 |
p. 1436-1437 |
artikel |
20 |
SPARCing the clot
|
van Os, Bram |
|
|
137 |
11 |
p. 1441-1442 |
artikel |
21 |
Specialized regulatory T cells control venous blood clot resolution through SPARC
|
Shahneh, Fatemeh |
|
|
137 |
11 |
p. 1517-1526 |
artikel |
22 |
Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group
|
Giulino-Roth, Lisa |
|
|
137 |
11 |
p. 1449-1456 |
artikel |
23 |
Subsequent neoplasms in pediatric Hodgkin lymphoma
|
|
|
|
137 |
11 |
p. 1562 |
artikel |
24 |
Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease
|
Ansari, Junaid |
|
|
137 |
11 |
p. 1538-1549 |
artikel |
25 |
Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma
|
Xu, Yujia |
|
|
137 |
11 |
p. 1478-1490 |
artikel |
26 |
Treon SP, Castillo JJ, Skarbnik AP, et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients. Blood. 2020;135(21):1912–1915.
|
|
|
|
137 |
11 |
p. 1561 |
artikel |